Growth hormone and insulin-like growth factor-I enhance β- glucuronidase gene activation by androgen in mouse kidney

Molecular and Cellular Endocrinology

Volumn 153, Issue 1-2, 1999, Pages 47-55

  Niermann, Gemma L ^a   Watson, Gordon L ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Glucuronidase; Androgen; Growth hormone; Hormone interaction; IGF I

Indexed keywords

ANDROGEN; BETA GLUCURONIDASE; ESTROGEN; GROWTH HORMONE; SOMATOMEDIN C; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; GENE ACTIVATION; HORMONAL REGULATION; HORMONE BINDING; HORMONE RESPONSE; HYPOPHYSECTOMY; KIDNEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE; SIGNAL TRANSDUCTION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DWARFISM; FEMALE; GLUCURONIDASE; GROWTH HORMONE; HYPOPHYSECTOMY; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; ORCHIECTOMY; PERIODICITY; RNA, MESSENGER; TESTOSTERONE;

EID: 0033587503     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00094-5     Document Type: Article

References (53)

1. Asfari M., De W., Postel-Vinay M.C., Czernichow P. Expression and regulation of growth hormone (GH) and prolactin (PRL) receptors in a rat insulin producing cell line (INS-1). Mol. Cell. Endocrinol. 107:1995;209-214.
2. Beato M., Candau R., Chávez S., Möws C., Truss M. Interaction of steroid hormone receptors with transcription factors involves chromatin remodelling. J. Steroid Biochem. Mol. Biol. 56:1996;47-59.
3. Behringer R.R., Lewin T.M., Quaife C.J., Palmiter R.D., Brinster R.L., D'Ercole A.J. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. Endocrinology. 127:1990;1033-1040.
4. Berger F.G., Watson G. Androgen-regulated gene expression. Annu. Rev. Physiol. 51:1989;51-65.
5. Bick T., Hochberg Z., Amit T., Isaksson O.G.P., Jansson J.-O. Roles of pulsatility and continuity of growth hormone (GH) administration in the regulation of hepatic GH-receptors, and circulating GH-binding protein and insulin-like growth factor-I. Endocrinology. 131:1992;423-429.
6. Birkenmeier E.H., Davisson M.T., Beamer W.G., Ganschow R.E., Vogler C.A., Gwynn B., Lyford K.A., Maltais L.M., Wawrzyniak C.J. Murine mucopolysaccharidosis type VII: characterization of a mouse with β-glucuronidase deficiency. J. Clin. Invest. 83:1989;1258-1266.
7. Blok L.J., deRuiter P.E., Brinkmann A.O. Androgen receptor phosphorylation. Endocr. Res. 22:1996;197-219.
8. Bush R.M., Paigen K. Evolution of β-glucuronidase regulation in the genus Mus. Evolution. 46:1992;1-15.
9. Cho H., Katzenellenbogen B.S. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol. Endocrinol. 7:1993;441-452.
10. Cox R.A. The use of guanidinium chloride in the isolation of nucleic acids. Methods Enzymol. 12B:1968;120-129.
11. Donahue L.R., Watson G., Beamer W.G. Regulation of metabolic water and protein compartments by insulin-like growth factor-I and testosterone in growth hormone-deficient lit/lit mice. J. Endocrinol. 139:1993;431-439.
12. Eakman G.D., Dallas J.S., Ponder S.W., Keenan B.S. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion. J. Clin. Endocrinol. Metab. 81:1996;1217-1223.
13. Edén S. Age- and sex-related differences in episodic growth hormone secretion in the rat. Endocrinology. 105:1979;555-560.
14. Fabre S., Darne C., Veyssiere G., Jean C. Protein kinase C pathway potentiates androgen-mediated gene expression of the mouse vas deferens specific aldose reductase-like protein (MVDP). Mol. Cell. Endocrinol. 124:1996;79-86.
15. Frohman M.A., Downs T.R., Chomczynski P., Frohman L.A. Cloning and characterization of mouse growth hormone-releasing hormone (GRH) complementary DNA: increased GRH messenger RNA levels in the growth hormone deficient lit/lit mouse. Mol. Endocrinol. 3:1989;1529-1536.
16. Holder A.T., Spencer E.M., Preece M.A. Effect of bovine growth hormone and a partially pure preparation of somatomedin on various growth parameters in hypopituitary dwarf mice. J. Endocrinol. 89:1981;275-282.
17. Ikonen T., Palvimo J.J., Kallio P.J., Reinikainen P., Jänne O.A. Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology. 135:1994;1359-1366.
18. Imai E., Miner J.N., Mitchell J.A., Yamamoto K.R., Granner D.K. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxylase gene to glucocorticoids. J. Biol. Chem. 268:1993;5353-5356.
19. Ingersoll D.W., Bobotas G., Lee C., Lukton A. β-Glucuronidase activation of latent aggression-promoting cues in mouse bladder urine. Physiol. Behav. 29:1982;789-793.
20. Isgaard J., Carlsson L., Isaksson O.G.P., Jansson J. Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. Endocrinology. 123:1988;2605-2610.
21. Jansson J., Edén S., Isaksson O. Sexual dimorphism in the control of growth hormone secretion. Endocr. Rev. 6:1985;128-150.
22. Jaussi R., Watson G., Paigen K. Modulation of androgen-responsive gene expression by estrogen. Mol. Cell. Endocrinol. 86:1992;187-192.
23. Kaji H., Ohashi S.-I., Abe H., Chihara K. Regulation of the growth hormone (GH) receptor and GH-binding protein mRNA. Proc. Soc. Exp. Biol. Med. 206:1994;257-262.
24. Katzenellenbogen B.S., Norman M.J. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: Interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen. Endocrinology. 126:1990;891-898.
25. Katzenellenbogen J.A., O'Malley B.W., Katzenellenbogen B.S. Tripartite steriod hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 10:1996;119-131.
26. Li S., Crenshaw III E.B., Rawson E.J., Simmons D.M., Swanson L.W., Rosenfeld M.G. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature. 347:1990;528-533.
27. Lund S.D., Gallagher P.M., Wang B., Porter S.C., Ganschow R.E. Androgen responsiveness of the murine β-glucuronidase gene is associated with nuclease hypersensitivity, protein binding, and haplotype-specific sequence diversity within intron 9. Mol. Cell. Biol. 11:1991;5426-5434.
28. Niermann G.L., Buehring G.C. Hormone regulation of bovine leukemia virus via the long terminal repeat. Virology. 239:1997;249-258.
29. Nordeen S.K., Moyer M.L., Bona B.J. The coupling of multiple signal transduction pathways with steroid response mechanisms. Endocrinology. 134:1994;1723-1732.
30. Norstedt G., Palmiter R. Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver. Cell. 36:1984;805-812.
31. Orian J.M., Snibson K., Stevenson J.L., Brandon M.R., Herington A.C. Elevation of growth hormone (GH) and prolactin receptors in transgenic mice expressing ovine GH. Endocrinology. 128:1991;1238-1246.
32. Ortí E., Bodwell J.E., Munck A. Phosphorylation of steroid hormone receptors. Endocr. Rev. 13:1992;105-128.
33. Owerbach D., Lusis A.J. Phenobarbital induction of egasyn: availability of egasyn in vivo determines glucuronidase binding to membrane. Biochem. Biophys. Res. Commun. 69:1976;628-634.
34. Paigen K. Experimental approaches to the study of regulatory evolution. Am. Nat. 134:1989;440-458.
35. Paigen K. Mammalian β-glucuronidase: genetics, molecular biology, and cell biology. Prog. Nucleic Acids Res. Mol. Biol. 37:1989;155-205.
36. Palmiter R.D., Norstedt G., Gelinas R., Hammer R.F., Brinster R.L. Metallothionein-human GH fusion genes stimulate growth of mice. Science. 222:1983;809-814.
37. Pan L., Koontz J. Insulin enhances glucocorticoid receptor-mediated induction of gene expression independent of a specific insulin response element. Arch. Biochem. Biophys. 316:1995;886-892.
38. Pfister K., Paigen K., Watson G., Chapman V. Expression of β-glucuronidase haplotypes in prototype and congenic mouse strains. Biochem. Genet. 20:1982;519-535.
39. Pfister K., Watson G., Chapman V., Paigen K. Kinetics of β-glucuronidase induction by androgen: genetic variation in the first order rate constant. J. Biol. Chem. 259:1984;5816-5820.
40. Pfister K., Chapman V., Watson G., Paigen K. Genetic variation for enzyme structure and systemic regulation in two new haplotypes of the β-glucuronidase gene of Mus musculus castaneus. J. Biol. Chem. 260:1985;11588-11594.
41. Philips A., Chalbos D., Rochefort H. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J. Biol. Chem. 268:1993;14103-14108.
42. Reinikainen P., Palvimo J.J., Janne O.A. Effects of mitogens on androgen receptor-mediated transactivation. Endocrinology. 137:1996;4351-4357.
43. Sanchez-Jimenez F., Fielder P.J., Martinez R.R., Smith W.C., Talamantes F. Hypophysectomy eliminates and growth hormone (GH) maintains the midpregnancy elevation in GH receptor and serum binding protein in the mouse. Endocrinology. 126:1990;1270-1275.
44. Swank R.T., Davey R., Joyce L., Reid P., Macey M.R. Differential effect of hypophysectomy on the synthesis of β-glucuronidase and other androgen-inducible enzymes in mouse kidney. Endocrinology. 100:1977;473-480.
45. Swank R.T., Paigen K., Davey R., Chapman V., Labarca C., Watson G., Ganschow R., Brandt E.J., Novak E. Genetic regulation of mammalian glucuronidase. Recent Prog. Horm. Res. 34:1978;401-436.
46. Swank R.T., Moore K., Chapman V.M. Abnormal subcellular distribution of β-glucuronidase in mice with a genetic alteration in enzyme structure. Biochem. Genet. 25:1987;161-174.
47. Thorton S., Thomas D.W., Gallagher P.M., Ganschow R.E. Androgen responsiveness of mouse kidney β-glucuronidase requires 5′-flanking and intragenic Gus-s sequences. Mol. Endocrinol. 12:1998;333-341.
48. Watson G., Paigen K. mRNA synthesis rates in vivo for androgen-inducible sequences in mouse kidney. Mol. Cell. Biol. 8:1988;2117-2124.
49. Watson G., Paigen K. Progressive induction of mRNA synthesis for androgen-responsive genes in mouse kidney. Mol. Cell. Endocrinol. 68:1990;67-74.
50. Watson G., Felder M., Rabinow L., Moore K., Labarca C., Tietze C., Vander Molen G., Bracey L., Brabant M., Cai J., Paigen K. Properties of rat and mouse β-glucuronidase mRNA and cDNA, including evidence for sequence polymorphism and genetic regulation of mRNA levels. Gene. 36:1985;15-25.
51. Watson G., Jaussi R., Tabron D., Paigen K. Gus-e locus regulates estrogen repression of androgen-induced β-glucuronidase expression in mouse kidney. Biochem. Genet. 31:1993;155-166.
52. Woodall S.M., Breier B.H., O'Sullivan U., Gluckman P.D. The effect of the frequency of subcutaneous insulin-like growth factor-1 administration on weight gain in growth hormone deficient mice. Horm. Metab. Res. 23:1991;581-584.
53. Yoshinaga S.K., Peterson C.L., Herskowitz I., Yamamoto K.R. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science. 258:1992;1598-1604.